Report Detail

Pharma & Healthcare Global GW788388 Market Research Report 2022

  • RnM4457719
  • |
  • 22 June, 2022
  • |
  • Global
  • |
  • 100 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

GW788388 is a potent and selective inhibitor of ALK5, also inhibits TGF-(beta) type II receptor and activin type II receptor activities.
Industry Insights

Due to the COVID-19 pandemic, the global GW788388 market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe GW788388 market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe GW788388 landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

0.99 accounting for % of the GW788388 global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Inhibitor of TGF-beta Type I Receptor Kinases segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of GW788388 include APExBIO Technology, Biorbyt, BOCSCI, Cayman Chemical, ChemScence, Creative Enzymes, Crysdot, Medical Isotopes and Tocris Bioscience, etc. In terms of revenue, the global 3 largest players have a % market share of GW788388 in 2021.

This report focuses on GW788388 volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall GW788388 market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the GW788388 market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Purity

0.99

0.98

0.95

Segment by Application

Inhibitor of TGF-beta Type I Receptor Kinases

Inhibitor of TGF-beta Type II Receptor Kinases

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

APExBIO Technology

Biorbyt

BOCSCI

Cayman Chemical

ChemScence

Creative Enzymes

Crysdot

Medical Isotopes

Tocris Bioscience

Toronto Research Chemicals

United States Biological

Howei Pharm

J&K Scientific

Shanghai Aladdin Biochemical Technology

Shanghai Bepharm Science&Technology

Shanghai ChangYan Chem & Tech

Shanghai Lollane Biological Technology

Shanghai Macklin Biochemical

Shanghaizehan Biopharma Technology

Frequently Asked Questions

Which product segment grabbed the largest share in the GW788388 market?

How is the competitive scenario of the GW788388 market?

Which are the key factors aiding the GW788388 market growth?

Which are the prominent players in the GW788388 market?

Which region holds the maximum share in the GW788388 market?

What will be the CAGR of the GW788388 market during the forecast period?

Which application segment emerged as the leading segment in the GW788388 market?

What key trends are likely to emerge in the GW788388 market in the coming years?

What will be the GW788388 market size by 2028?

Which company held the largest share in the GW788388 market?


1 GW788388 Market Overview

  • 1.1 Product Overview and Scope of GW788388
  • 1.2 GW788388 Segment by Purity
  • 1.2.1 Global GW788388 Sales Growth Rate Comparison by Purity (2022-2028)
  • 1.2.2 0.99
  • 1.2.3 0.98
  • 1.2.4 0.95
  • 1.3 GW788388 Segment by Application
  • 1.3.1 Global GW788388 Sales Comparison by Application: (2022-2028)
  • 1.3.2 Inhibitor of TGF-beta Type I Receptor Kinases
  • 1.3.3 Inhibitor of TGF-beta Type II Receptor Kinases
  • 1.4 Global GW788388 Market Size Estimates and Forecasts
  • 1.4.1 Global GW788388 Revenue 2017-2028
  • 1.4.2 Global GW788388 Sales 2017-2028
  • 1.4.3 GW788388 Market Size by Region: 2017 Versus 2021 Versus 2028
  • 2 GW788388 Market Competition by Manufacturers

    • 2.1 Global GW788388 Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global GW788388 Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global GW788388 Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers GW788388 Manufacturing Sites, Area Served, Product Type
    • 2.5 GW788388 Market Competitive Situation and Trends
    • 2.5.1 GW788388 Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest GW788388 Players Market Share by Revenue
  • 2.5.3 Global GW788388 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3 GW788388 Retrospective Market Scenario by Region

    • 3.1 Global GW788388 Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global GW788388 Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America GW788388 Market Facts & Figures by Country
    • 3.3.1 North America GW788388 Sales by Country
  • 3.3.2 North America GW788388 Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
  • 3.4 Europe GW788388 Market Facts & Figures by Country
  • 3.4.1 Europe GW788388 Sales by Country
  • 3.4.2 Europe GW788388 Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
  • 3.5 Asia Pacific GW788388 Market Facts & Figures by Region
  • 3.5.1 Asia Pacific GW788388 Sales by Region
  • 3.5.2 Asia Pacific GW788388 Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.6 Latin America GW788388 Market Facts & Figures by Country
  • 3.6.1 Latin America GW788388 Sales by Country
  • 3.6.2 Latin America GW788388 Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.7 Middle East and Africa GW788388 Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa GW788388 Sales by Country
  • 3.7.2 Middle East and Africa GW788388 Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE
  • 4 Global GW788388 Historic Market Analysis by Purity

    • 4.1 Global GW788388 Sales Market Share by Purity (2017-2022)
    • 4.2 Global GW788388 Revenue Market Share by Purity (2017-2022)
    • 4.3 Global GW788388 Price by Purity (2017-2022)

    5 Global GW788388 Historic Market Analysis by Application

    • 5.1 Global GW788388 Sales Market Share by Application (2017-2022)
    • 5.2 Global GW788388 Revenue Market Share by Application (2017-2022)
    • 5.3 Global GW788388 Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 APExBIO Technology
    • 6.1.1 APExBIO Technology Corporation Information
  • 6.1.2 APExBIO Technology Description and Business Overview
  • 6.1.3 APExBIO Technology GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 APExBIO Technology GW788388 Product Portfolio
  • 6.1.5 APExBIO Technology Recent Developments/Updates
  • 6.2 Biorbyt
  • 6.2.1 Biorbyt Corporation Information
  • 6.2.2 Biorbyt Description and Business Overview
  • 6.2.3 Biorbyt GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 Biorbyt GW788388 Product Portfolio
  • 6.2.5 Biorbyt Recent Developments/Updates
  • 6.3 BOCSCI
  • 6.3.1 BOCSCI Corporation Information
  • 6.3.2 BOCSCI Description and Business Overview
  • 6.3.3 BOCSCI GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 BOCSCI GW788388 Product Portfolio
  • 6.3.5 BOCSCI Recent Developments/Updates
  • 6.4 Cayman Chemical
  • 6.4.1 Cayman Chemical Corporation Information
  • 6.4.2 Cayman Chemical Description and Business Overview
  • 6.4.3 Cayman Chemical GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Cayman Chemical GW788388 Product Portfolio
  • 6.4.5 Cayman Chemical Recent Developments/Updates
  • 6.5 ChemScence
  • 6.5.1 ChemScence Corporation Information
  • 6.5.2 ChemScence Description and Business Overview
  • 6.5.3 ChemScence GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 ChemScence GW788388 Product Portfolio
  • 6.5.5 ChemScence Recent Developments/Updates
  • 6.6 Creative Enzymes
  • 6.6.1 Creative Enzymes Corporation Information
  • 6.6.2 Creative Enzymes Description and Business Overview
  • 6.6.3 Creative Enzymes GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 Creative Enzymes GW788388 Product Portfolio
  • 6.6.5 Creative Enzymes Recent Developments/Updates
  • 6.7 Crysdot
  • 6.6.1 Crysdot Corporation Information
  • 6.6.2 Crysdot Description and Business Overview
  • 6.6.3 Crysdot GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Crysdot GW788388 Product Portfolio
  • 6.7.5 Crysdot Recent Developments/Updates
  • 6.8 Medical Isotopes
  • 6.8.1 Medical Isotopes Corporation Information
  • 6.8.2 Medical Isotopes Description and Business Overview
  • 6.8.3 Medical Isotopes GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 Medical Isotopes GW788388 Product Portfolio
  • 6.8.5 Medical Isotopes Recent Developments/Updates
  • 6.9 Tocris Bioscience
  • 6.9.1 Tocris Bioscience Corporation Information
  • 6.9.2 Tocris Bioscience Description and Business Overview
  • 6.9.3 Tocris Bioscience GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 Tocris Bioscience GW788388 Product Portfolio
  • 6.9.5 Tocris Bioscience Recent Developments/Updates
  • 6.10 Toronto Research Chemicals
  • 6.10.1 Toronto Research Chemicals Corporation Information
  • 6.10.2 Toronto Research Chemicals Description and Business Overview
  • 6.10.3 Toronto Research Chemicals GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.10.4 Toronto Research Chemicals GW788388 Product Portfolio
  • 6.10.5 Toronto Research Chemicals Recent Developments/Updates
  • 6.11 United States Biological
  • 6.11.1 United States Biological Corporation Information
  • 6.11.2 United States Biological GW788388 Description and Business Overview
  • 6.11.3 United States Biological GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.11.4 United States Biological GW788388 Product Portfolio
  • 6.11.5 United States Biological Recent Developments/Updates
  • 6.12 Howei Pharm
  • 6.12.1 Howei Pharm Corporation Information
  • 6.12.2 Howei Pharm GW788388 Description and Business Overview
  • 6.12.3 Howei Pharm GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.12.4 Howei Pharm GW788388 Product Portfolio
  • 6.12.5 Howei Pharm Recent Developments/Updates
  • 6.13 J&K Scientific
  • 6.13.1 J&K Scientific Corporation Information
  • 6.13.2 J&K Scientific GW788388 Description and Business Overview
  • 6.13.3 J&K Scientific GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.13.4 J&K Scientific GW788388 Product Portfolio
  • 6.13.5 J&K Scientific Recent Developments/Updates
  • 6.14 Shanghai Aladdin Biochemical Technology
  • 6.14.1 Shanghai Aladdin Biochemical Technology Corporation Information
  • 6.14.2 Shanghai Aladdin Biochemical Technology GW788388 Description and Business Overview
  • 6.14.3 Shanghai Aladdin Biochemical Technology GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.14.4 Shanghai Aladdin Biochemical Technology GW788388 Product Portfolio
  • 6.14.5 Shanghai Aladdin Biochemical Technology Recent Developments/Updates
  • 6.15 Shanghai Bepharm Science&Technology
  • 6.15.1 Shanghai Bepharm Science&Technology Corporation Information
  • 6.15.2 Shanghai Bepharm Science&Technology GW788388 Description and Business Overview
  • 6.15.3 Shanghai Bepharm Science&Technology GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.15.4 Shanghai Bepharm Science&Technology GW788388 Product Portfolio
  • 6.15.5 Shanghai Bepharm Science&Technology Recent Developments/Updates
  • 6.16 Shanghai ChangYan Chem & Tech
  • 6.16.1 Shanghai ChangYan Chem & Tech Corporation Information
  • 6.16.2 Shanghai ChangYan Chem & Tech GW788388 Description and Business Overview
  • 6.16.3 Shanghai ChangYan Chem & Tech GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.16.4 Shanghai ChangYan Chem & Tech GW788388 Product Portfolio
  • 6.16.5 Shanghai ChangYan Chem & Tech Recent Developments/Updates
  • 6.17 Shanghai Lollane Biological Technology
  • 6.17.1 Shanghai Lollane Biological Technology Corporation Information
  • 6.17.2 Shanghai Lollane Biological Technology GW788388 Description and Business Overview
  • 6.17.3 Shanghai Lollane Biological Technology GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.17.4 Shanghai Lollane Biological Technology GW788388 Product Portfolio
  • 6.17.5 Shanghai Lollane Biological Technology Recent Developments/Updates
  • 6.18 Shanghai Macklin Biochemical
  • 6.18.1 Shanghai Macklin Biochemical Corporation Information
  • 6.18.2 Shanghai Macklin Biochemical GW788388 Description and Business Overview
  • 6.18.3 Shanghai Macklin Biochemical GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.18.4 Shanghai Macklin Biochemical GW788388 Product Portfolio
  • 6.18.5 Shanghai Macklin Biochemical Recent Developments/Updates
  • 6.19 Shanghaizehan Biopharma Technology
  • 6.19.1 Shanghaizehan Biopharma Technology Corporation Information
  • 6.19.2 Shanghaizehan Biopharma Technology GW788388 Description and Business Overview
  • 6.19.3 Shanghaizehan Biopharma Technology GW788388 Sales, Revenue and Gross Margin (2017-2022)
  • 6.19.4 Shanghaizehan Biopharma Technology GW788388 Product Portfolio
  • 6.19.5 Shanghaizehan Biopharma Technology Recent Developments/Updates
  • 7 GW788388 Manufacturing Cost Analysis

    • 7.1 GW788388 Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of GW788388
  • 7.4 GW788388 Industrial Chain Analysis
  • 8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 GW788388 Distributors List
    • 8.3 GW788388 Customers

    9 GW788388 Market Dynamics

    • 9.1 GW788388 Industry Trends
    • 9.2 GW788388 Market Drivers
    • 9.3 GW788388 Market Challenges
    • 9.4 GW788388 Market Restraints

    10 Global Market Forecast

    • 10.1 GW788388 Market Estimates and Projections by Purity
    • 10.1.1 Global Forecasted Sales of GW788388 by Purity (2023-2028)
  • 10.1.2 Global Forecasted Revenue of GW788388 by Purity (2023-2028)
  • 10.2 GW788388 Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of GW788388 by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of GW788388 by Application (2023-2028)
  • 10.3 GW788388 Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of GW788388 by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of GW788388 by Region (2023-2028)
  • 11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
    • 12.3 Author List
    • Summary:
      Get latest Market Research Reports on GW788388. Industry analysis & Market Report on GW788388 is a syndicated market report, published as Global GW788388 Market Research Report 2022. It is complete Research Study and Industry Analysis of GW788388 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,404.10
      4,808.20
      2,781.10
      5,562.20
      392,921.00
      785,842.00
      229,042.00
      458,084.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report